Montreal Neurological Hospital Research Pharmacy
Montreal, Quebec, Canada
University hospital in Montreal, Quebec
3801 Rue University, Montréal, QC H3A 2B4
85 Beds
About Montreal Neurological Hospital Research Pharmacy
The Montreal Neurological Institute-Hospital, also known as Montreal Neuro or The Neuro, is a research and medical centre dedicated to neuroscience, training and clinical care, located in the city's downtown core of Montreal, Quebec, Canada.
There are 85 beds in Montreal Neurological Hospital Research Pharmacy.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Montreal Neurological Hospital Research Pharmacy
During the past decade, Montreal Neurological Hospital Research Pharmacy conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
1996-06-01
2012-03-01
Completed
221
Combination Chemotherapy in Treating Children With Progressive Brain Tumors
1997-04-01
2012-04-01
Completed
428
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma
2000-06-01
2015-03-31
Completed
393
S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma
2001-03-01
2023-06-01
Active, not recruiting
571
Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma
2001-05-01
2012-03-01
Completed
66
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
2003-08-01
2016-03-31
Completed
378
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Montreal Neurological Hospital Research Pharmacy
According to Clinical.Site data, the most researched conditions in "Montreal Neurological Hospital Research Pharmacy" are
"Parkinson Disease" (1 trials) and "Staphylococcal Vaccine" (1 trials). Many other conditions were trialed in "Montreal Neurological Hospital Research Pharmacy" in a lesser frequency.
Clinical Trials Intervention Types at Montreal Neurological Hospital Research Pharmacy
Most popular intervention types in "Montreal Neurological Hospital Research Pharmacy" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "PF-06649751 high dose (15 mg QD)" (1 trials), "PF-06649751 low dose (1 mg QD)" (1 trials), "PF-06649751 middle dose 1 (3 mg QD)" (1 trials) and "PF-06649751 middle dose 2 (7 mg QD)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Montreal Neurological Hospital Research Pharmacy
The vast majority of trials in "Montreal Neurological Hospital Research Pharmacy" are
2 trials for "All" genders.
Clinical Trials Status at Montreal Neurological Hospital Research Pharmacy
Currently, there are NaN active trials in "Montreal Neurological Hospital Research Pharmacy".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Montreal Neurological Hospital Research Pharmacy,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Montreal Neurological Hospital Research Pharmacy, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".